Rchr
J-GLOBAL ID:201801000013626802
Update date: Oct. 14, 2024
Yosuke Suzuki
スズキ ヨウスケ | Yosuke Suzuki
Affiliation and department:
Research field (1):
Clinical pharmacy
Research theme for competitive and other funds (6):
- 2024 - 2028 Clinical pharmacology studies to explore the optimal therapeutic strategy of novel antibody agents in systemic lupus erythematosus
- 2022 - 2025 Development of useful new biomarkers to predict the severity and prognosis of vasculitis syndrome
- 2022 - 2025 ゲノム・オミックス情報を駆使した薬物動態関連バイオマーカーの網羅的探索研究
- 2019 - 2022 Physiological factors involved in variability of OATP1B activity
- 2015 - 2018 Establishment of MR-proADM as novel biomarker for individualization of antihypertensive therapy in renal failure patient
- 2015 - 2017 Significant factors associated with the decrease in CYP3A activity in patients with chronic renal failure
Show all
Papers (73):
-
Chisato Yoshijima, Yosuke Suzuki, Ryota Tanaka, Hiroyuki Ono, Ayako Oda, Takashi Ozaki, Hirotaka Shibata, Hiroki Itoh, Keiko Ohno. Evaluation of intra- and inter-individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus. Pharmacology Research & Perspectives. 2024. 12. 4
-
Ayako Oda, Yosuke Suzuki, Haruki Sato, Teruhide Koyama, Masahiro Nakatochi, Yukihide Momozawa, Ryota Tanaka, Hiroyuki Ono, Ryosuke Tatsuta, Tadasuke Ando, et al. Evaluation of the usefulness of plasma 4β-hydroxycholesterol concentration normalized by 4α-hydroxycholesterol for accurate CYP3A phenotyping. Clinical and Translational Science. 2024. 17. 3
-
Hiroyuki Ono, Ryota Tanaka, Yosuke Suzuki, Ayako Oda, Haruki Sato, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Keiko Ohno, Hiroki Itoh. Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease. Clinical and Translational Science. 2024. 17. 2
-
Chisato Yoshijima, Yosuke Suzuki, Ryota Tanaka, Hiroyuki Ono, Ayako Oda, Takashi Ozaki, Hirotaka Shibata, Hiroki Itoh, Keiko Ohno. Rapid and simple quantification of belimumab in human plasma using ultra-high performance liquid chromatography with tandem mass spectrometry. Clinical biochemistry. 2024. 124. 110706-110706
-
Chisato Yoshijima, Yosuke Suzuki, Ayako Oda, Ryota Tanaka, Hiroyuki Ono, Hiroki Itoh, Keiko Ohno. Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review. Current Therapeutic Research. 2024. 100. 100738-100738
more...
MISC (105):
-
鈴木 陽介. Overview TDM研究のエビデンス化に向けて. TDM研究. 2024. 41. 2. 125-125
-
根上 純, 鈴木 陽介, 小田 絢子, 飯野 滉大, 神尾 奈月, 鈴木 さくら, 山岸 尚, 小山 晃英, 大野 恵子. メタボローム解析によるorganic anion transporting polypeptide 1B1および1B3活性を反映する新規バイオマーカーの探索. TDM研究. 2024. 41. 2. 186-186
-
鈴木 陽介. 【血中濃度の変動要因を見極めよう 悩ましい薬物動態の諸問題】最新Topics バイオマーカーを活用した病態時の薬物代謝酵素および薬物トランスポーター活性の評価. 薬事. 2024. 66. 3. 582-585
-
神尾奈月, 鈴木陽介, 飯野滉大, 鈴木さくら, 山岸尚, 小山晃英, 小田絢子, 大野恵子. Search for novel biomarkers of cytochrome P450 2D6 through genome-wide association study and metabolomics-Solid phase extraction by reversed phase-strong anion exchange mixed mode-. 日本薬学会年会要旨集(Web). 2024. 144th
-
鈴木さくら, 鈴木陽介, 飯野滉大, 山岸尚, 神尾奈月, 小山晃英, 小田絢子, 大野恵子. Search for endogenous biomarker of CYP2C19 using genome-wide association study and metabolomics-Solid phase extraction by reversed phase-strong anion exchanged mixed mode-. 日本薬学会年会要旨集(Web). 2024. 144th
more...
Work history (4):
- 2021/04 - 現在 Meiji Pharmaceutical University
- 2018/07 - 2021/03 Meiji Pharmaceutical University Department of Medication Use Analysis and Clinical Research Assistant Professor
- 2012/08 - 2018/06 Oita University Hospital Department of Clinical Pharmacy Chief Pharmacist
- 2009/04 - 2012/07 Oita University Hospital Department of Clinical Pharmacy Pharmacist
Return to Previous Page